iof_wco_logo.gif

IOF World Congress on Osteoporosis 2004,
Rio de Janeiro
See abstracts and press releases

Would you like to learn more about IOF and its activities?
Visit the IOF website

Second announcement
Download second announcement (PDF, 452 KB)

Download the powerpoint slide announcing the congress (PowerPoint, 638 KB)

Meet the Expert Sessions

Saturday June 3, 2006

Each Session is held both at 11:30 – 12:30 and 13:15 – 14:15

Jonathan D. Adachi
 
Corticosteroid-induced Osteoporosis
Steven Boonen Clinical Aspects of Osteoporosis in the Oldest Old
Steve R. Cummings Future Treatments for Osteoporosis
John A. Eisman Genetic Aspects of Osteoporosis
Dieter Felsenberg Disuse, Low gravity and Bone
Harry K. Genant Vertebral Fracture Assessment
Marius Kraenzlin Practical Use of Osteodensitometry
Paul Lips Evaluation of Quality of Life
L. Joseph Melton Epidemiology of Osteoporosis: Study Design
Lawrence G. Raisz Practical Use of Biochemical Markers
Ego Seeman Bone Architecture, Matrix Properties and Fracture Risk
Elisabeth Shane Secondary Causes of Osteoporosis

Sunday June 4, 2006

Each Session is held both at 11:30 – 12:30 and 13:15 – 14:15

John P. Bilezikian
 
Bone Anabolic Treatments and its Monitoring
Jean-Philippe Bonjour Bone Growth in Childhood and Adolescence
Peter Burckhardt Calcium and Vitamin D in Osteoporosis Management
Juliet E. Compston Management of Osteoporosis before Menopause
Bess Dawson-Hughes Nutrition Counselling of Osteoporotic Patients
Richard Eastell Compliance to Osteoporosis Therapy
J. Cranford and Karen Ormerod Actions to Make Osteoporosis a Priority on Payers' Healthcare Agenda
David Marsh Post Fracture Management
Helmut W. Minne Physical Rehabilitation and Prevention of Falls
Eric Orwoll Osteoporosis in Men
Jean-Yves Reginster Current Management of Osteoarthritis
Ethel Siris Place of HRT in the management of osteoporosis

Monday June 5, 2006

Each Session is held both at 11:30 – 12:30 and 13:15 – 14:15

Silvano Adami
 
Management of Osteoporosis Imperfecta in Adults
Claude Arnaud Combination or Sequential Therapy in Osteoporosis
Fredrik Borgström Cost-Utility of Osteoporosis Treatment
Maria Luisa Brandi Pharmacogenetics
Cyrus Cooper Epidemiology and Health Impact of Osteoarthritis
David Goltzman New Therapeutic Targets in Osteoporosis
Anthony B. Hodsman Cost-Utility of Anabolic Treatment
Olof Johnell Burden of Osteoporosis and Health Economics
Robert G. Josse Cancer Treatment-induced Bone Loss
Uri Liberman Case-Solving Studies
Paul D. Miller Bisphosphonates in Renal Osteodystrophy
Nelson B. Watts How Long Should We Treat?

Page Top